20 Oct 2009 --- Mangosteen juice has anti-inflammatory properties which could prove to be valuable in preventing the development of heart disease and diabetes in obese patients.  A study, published in BioMed Central’s open access Nutrition Journal, describes how the juice of the exotic ‘superfruit’ lowered levels of C-reactive protein.

Dr. Jay Udani, M.D. from Medicus Research, California, worked with a team of researchers to carry out a randomized, double-blind placebo controlled trial. He said, “For people drinking over half a liter of mangosteen juice a day, the degree of reduction in CRP levels was statistically significant – a reduction of 1.33mg/L compared to an increase of 0.9mg/L in the placebo group”.

Inflammation, as measured here by CRP, is a predictor of cardiovascular disease and a precursor of metabolic syndrome. Reducing inflammation in obese people is a treatment goal, and a natural treatment may be preferable to other treatments which may carry the risk of side effect. According to Udani, “Further studies with a larger population are required to confirm and further define the benefits of this juice, which was safe at all dosages tested”. 

Full bibliographic information: Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study.
Jay K Udani, Betsy B Singh, Marilyn L Barrett and Vijay J Singh
Nutrition Journal (in press)